Xconomy

OCTOBER 7, 2016

. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

AUGUST 19, 2016

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Data from the other three trials should come in late 2016 or early 2017.

Technical Review 40

Technical Review Patents .Net Study 40

Tech.Co

DECEMBER 15, 2017

According to one study, there were over 835,000 people working out of coworking spaces last year. The number of coworking spaces alone is expected to jump from 11,300 in 2016 to 13,800 by the end of this year. In a coworking space, you have people working diligently all around you.

Technical Review 90

Technical Review Study Web Design Startup 90

Both Sides of the Table

MARCH 25, 2016

Many startup businesses – tech or otherwise – fail. Trying outrageous new things or even trying mundane things but in new ways but with extreme quality & innovation is what fuels the tech startup industry. But that’s harder to build in 2016 than it was in say 2005. No, thanks.

Startup 150

Startup Marketing Study SEO 150

Xconomy

AUGUST 12, 2016

government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. That story and the rest of the week’s biotech headlines below. —The U.S. —David H.

Google 40

Google Technical Review News Research 40